3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Lymphoid
1
Conditions
Carcinoma, Non-Small-Cell Lung
9
Head and Neck Neoplasms
4
Small Cell Lung Carcinoma
3
Lymphoma, Extranodal NK-T-Cell
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Uterine Cervical Neoplasms
1
Squamous Non-small-cell Lung Cancer
1
Squamous Cell Carcinoma of Head and Neck
1
Non-Small Cell Lung Cancer Metastatic
1
Neuroendocrine Tumors
1
Neoplasm Metastasis
1
Nasopharyngeal Neoplasms
1
Melanoma
1
Medulloblastoma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Mantle-Cell
1
Lymphohistiocytosis, Hemophagocytic
1
Lung Neoplasms
1
Locally Advanced Malignant Neoplasm
1
Intracranial Germ Cell Tumors
1
Carcinoma, Squamous Cell
1
Cancer Therapy-related Cardiovascular Toxicity
1
Anemia
1
Adenocarcinoma of Lung
1
Interventions
zanubrutinib
1
ruxolitinib
1
pegaspargase
1
Rituximab
1
Gemcitabine
1
Etoposide
1
Dexamethasone
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Lymphohistiocytosis, Hemophagocytic
×
Cisplatin
×
Clear all
NCT04999878
2021-08-11
RUE-DDGP
Zhengzhou University
Phase 4
Unknown
30 enrolled